1. Preventing Thrombotic Complications in ACS: State of the Art

3. 79-Year-Old Woman: Presentation

4. 79-Year-Old Woman (cont)

5. GRACE ACS Risk Model: Score in-hospital to 6 Months

6. GRACE ACS Risk Model: Risk in-hospital to 6 Months

7. 79-Year-Old Woman: CCU

8. 79-Year-Old Woman (cont)

9. 79-Year-Old Woman: Catheterization

10. 79-Year-Old Woman: CABG

11. 79-Year-Old Woman: Discharge

12. 79-Year-Old Woman: Stable Angina

13. Prasugrel in the Elderly

14. PLATO: All-cause Mortality in the Overall and CABG Subpopulation

15. PLATO: All-cause Death and Major Bleeding in the CKD Subgroup

16. PLATO CABG Substudy: Bleeding-related Deaths at 12 Months

17. 2015 ESC Guidance on Use of Antiplatelet Therapy in NSTE-ACS

18. 2015 ESC Guidance on Interrupting Antiplatelet Therapy in NSTE-ACS

19. 39-Year-Old Man: Presentation

20. 39-Year-Old Man: Medical History

21. 39-Year-Old Man: Vital Signs and Physical Exam

22. 39-Year-Old Man: ECG

23. 39-Year-Old Man: Transferred for Cath

24. 39-Year-Old Man: Coronary Angiogram, 3:19 PM

25. 39-Year-Old Man: 3:19 PM

26. 39-Year-Old Man: 3:24 PM

27. 39-Year-Old Man: 3:27 PM

28. 39-Year-Old Man: 3:34 PM

29. 39-Year-Old Man: Final Result

30. 39-Year-Old Man: Antiplatelet Therapy

31. 39-Year-Old Man: 2 Days Post-STEMI

32. 39-Year-Old Man: 1 Year Post-STEMI

33. DAPT: Long-term DAPT in DES Patients, Months 12-30

34. DAPT: GUSTO Bleeding, Severe or Moderate, Months 12-30

35. DAPT: Major Adverse CV and Cerebrovascular Events by Subgroup

36. DAPT: Mortality Outcomes

37. DAPT: Outcomes at 12 to 30 Months Post-Stent, MI/No MI

38. PEGASUS-TIMI 54: Trial Design

39. PEGASUS-TIMI 54: Primary Endpoint

40. PEGASUS-TIMI 54: Subgroup Analysis of the Primary Endpoint

41. PEGASUS-TIMI 54: Bleeding Outcomes

42. Extended Dual Antiplatelet Therapy vs Aspirin Alone: Meta-analysis

43. DAPT Risk Score

44. Abbreviations

45. Abbreviations (cont)

46. Abbreviations (cont)